SCHEMBL4385833

SCHEMBL4385833

CC(=O)NCCc1cscn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
F13A1 P00488 1/20 0.42
QPCT Q16769 1/20 0.41
QPCTL Q9NXS2 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ACACB O00763 2/20 0.41
PKM P14618 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HIF1A Q16665 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
PTGS1 P23219 1/20 0.39
BLM P54132 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MTNR1A P48039 5/20 0.39
MAPK1 P28482 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6679224 0.84 NPC1 (0.42) KDM4ENPC1RAB9APKMNPSR1
SCHEMBL6099838 0.84 NPSR1 (0.52) KDM4EPKMNPSR1SMN1; SMN2ALDH1A1
SCHEMBL28899641 0.79 HTT (0.44) NPSR1ALDH1A1MAPTHTT
Malonic Acid SCHEMBL6672043 0.78 NPSR1 (0.46) KDM4EPKMNPSR1ALDH1A1MAPT
SCHEMBL18381305 0.75 CA1 (0.45) KDM4ENPC1RAB9APKMALDH1A1
SCHEMBL18381334 0.73 HDAC3 (0.40) KDM4ENPC1RAB9APKMSMN1; SMN2
SCHEMBL16252212 0.72 MAPK1 (0.38) KDM4ERAB9APKMNPSR1SMN1; SMN2
SCHEMBL7270380 0.72 TSHR (0.40) KDM4EPKMNPSR1SMN1; SMN2ALDH1A1
SCHEMBL16889110 0.72
SCHEMBL6683078 0.71 TAAR1 (0.41) KDM4ENPC1RAB9APKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612075-B2 Substituted oxoazaheterocyclyl compounds AVENTIS PHARMACEUTICALS INC. (US) 2009-11-03 US disclosed
WO-2000032590-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 2000-06-08 WO disclosed